Eldisine (vindesine) supply shortage
Submitted by Anonymous (not verified) on 23 February 2024 - 16:12
Eldisine (vindesine) supply shortage
Clinical Trial Information System (CTIS) evaluation timelines
Submitted by Anonymous (not verified) on 23 February 2024 - 15:32
Clinical Trial Information System (CTIS) evaluation timelines
CTIS Training materials - Latest updates
Submitted by Anonymous (not verified) on 23 February 2024 - 15:29
CTIS Training materials - Latest updates
Membership list: HMA-EMA joint Big Data Steering Group
Submitted by Anonymous (not verified) on 23 February 2024 - 13:44
Membership list: HMA-EMA joint Big Data Steering Group
Human medicines European public assessment report (EPAR): Fuzeon, enfuvirtide, Date of authorisation: 27/05/2003, Revision: 25, Status: Authorised
Submitted by Anonymous (not verified) on 23 February 2024 - 13:25
Human medicines European public assessment report (EPAR): Fuzeon, enfuvirtide, Date of authorisation: 27/05/2003, Revision: 25, Status: Authorised
Infographic - Orphan Medicines in the EU
Submitted by Anonymous (not verified) on 23 February 2024 - 12:36
Infographic - Orphan Medicines in the EU
Signal Management Review Technical (SMART) Working Group
Submitted by Anonymous (not verified) on 23 February 2024 - 11:40
Signal Management Review Technical (SMART) Working Group
Pharmacovigilance-related recommendations to product information for centrally authorised veterinary medicines
Submitted by Anonymous (not verified) on 23 February 2024 - 11:08
Pharmacovigilance-related recommendations to product information for centrally authorised veterinary medicines
Start of Union reviews adopted during the CHMP meeting of 19-22 February 2024
Submitted by Anonymous (not verified) on 23 February 2024 - 11:00
Start of Union reviews adopted during the CHMP meeting of 19-22 February 2024
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 February 2024
Submitted by Anonymous (not verified) on 23 February 2024 - 11:00
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 February 2024